SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

Multiple people are facing felony drug charges after an investigation in Nashua that spanned several years, police said.The Nashua Police Department said in fall 2023, members of the Narcotics ...

United States Marine Corps troops patrol the U.S.-Mexico border area near San Diego in February. The Defense Department has deployed hundreds of active-duty troops to the region. (NurPhoto via ...

Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for an abbreviated new drug application for Ticagrelor Tablets 90 mg and tentative approval for Ticagrelor ...

WASHINGTON -- The Trump administration on Thursday imposed economic sanctions on three Mexican nationals and two Mexico-based entities involved in a drug trafficking and fuel theft network linked ...

New Delhi [India], April 30 (ANI): Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. The Tribune, now published from ...

Just two years ago, the US was suffering through the worst stretch of its long-running drug overdose crisis. More than 110,000 Americans had died in the previous 12 months from an overdose ...

The Food and Drug Administration on Wednesday approved an antibody drug that developer Johnson & Johnson expects will eventually become one of its top-selling medicines. The drug, which J&J will sell ...

Announced Wednesday, the acquisition will hand the Swiss pharmaceutical firm a drug prospect called farabursen, which recently completed a Phase 1b study in people with autosomal dominant polycystic ...

It’s worth noting that Ajaz Khan himself was previously arrested in 2021 by the Narcotics Control Bureau (NCB) in a separate drug case. He was later released on bail. Most recently, he contested ...

The drug maker on Tuesday announced a new 470,000-square-foot facility in Wilmington, Delaware, where it will make Keytruda, the company's immunotherapy treatment for different cancers.